More NewsRead More
OncoGenex Announces Update on Phase 3 ENSPIRIT Trial Evaluating Custirsen in Advanced Non-Small Cell Lung Cancer
August 21, 2014
OncoGenex Pharmaceuticals Announces Appointment of John A. Bencich as Vice President and Chief Financial Officer
August 07, 2014
OncoGenex Announces Cedar™ Clinical Trial Evaluating Apatorsen in Combination with Chemotherapy in Advanced Squamous Cell Lung Cancer is Now Open for Enrollment
July 01, 2014
OncoGenex Pharmaceuticals Announces Pricing of $24 Million Underwritten Registered Direct Offering
June 26, 2014
OncoGenex Pharmaceutical: The Losing Streak Continues (OGXI)
October 01, 2014
OncoGenex Pharma (OGXI) Completes Enrollment in AFFINITY Phase 3
September 16, 2014
Active Stocks: Merck, OncoGenex, Ibio, OraSure, AbbVie
October 16, 2014
from Blogs - TalkMarkets
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here